Nonetheless, preclinical studies offer valuable insights: for example, CTLA-4-deficient mice develop fatal myocarditis early in life, underscoring the essential role of CTLA-4 in maintaining immune tolerance to cardiac tissue (180, 181). This evidence concerns the gene CTLA4 and myocarditis.